Targeting SIX2 as a novel sensitization strategy of sorafenib treatment on advanced hepatocellular carcinoma through modulating METTL9-SLC7A11 axis.
通过调节 METTL9-SLC7A11 轴,以 SIX2 为靶点,作为索拉非尼治疗晚期肝细胞癌的新型增敏策略
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01004-6
Lu Junren, Cai Daming, Qian Long, Wang Yurong, Ai Shichao, Song Peng, Sun Feng, Sun Yiwen, Liang Mengjie, Jiang Hang, Wang Xingzhou, Wang Meng, Lu Xiaofeng, Guan Wenxian, Shen Xiaofei